PBTQ Gains, Lifted by Celgene, Genzyme Friday, October 1, 8:43 AM ET, by Market News Video Staff The PowerShares Global Biotech Portfolio (PBTQ) has a market value of only $3.7 million, but ...
IBB Sees Heavy Shorting, Largest Holding Amgen Monday, October 25, 10:08 AM ET, by Market News Video Staff There are 7,884,900 shares short of the iShares Nasdaq Biotechnology Index Fund (IBB) according to ...
COV Beats Expectations Tuesday, November 9, 11:42 AM ET, by Market News Video Staff Irish medical device maker Covidien (COV) posted a surge in fourth quarter earnings that beat ...
CELG Crosses Below Key Moving Average Level Monday, April 18, 2:17 PM ET, by Market News Video Staff In trading on Monday, shares of Celgene Corp. (CELG) crossed below their 200 day moving ...
In trading on Friday, shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) crossed below their 200 day moving average of $7.25, changing hands as low as $7.03 per share. Neurocrine Biosciences, Inc. shares are currently trading off about 1.9% on the day. The chart below shows the one year performance of NBIX shares, versus its 200 day moving average:
Looking at the chart above, NBIX's low point in its 52 week range is $4.09 per share, with $9.30 as the 52 week high point — that compares with a last trade of $7.21.
NBIX operates in the Biotechnology sector, among companies like Thermo Fisher Scientific Inc (NYSE:TMO) which is off about 0.7% today, and Celgene Corp. (NASDAQ:CELG) trading lower by about 0.9%. Below is a three month price history chart comparing the stock performance of NBIX, versus TMO and CELG.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AccordingBelowBiosciencesBiotechnologyCELGChannelETFsFridayGenomeInvestmentMovingNASDAQNBIXNeurocrinePortfolioScientificaboutallowsamongassetaveragebelowchartcompaniescompletelycurrentlydesignedgrowthhandshistorylowermovingoperatesotherperformancepointportfoliopricerangesharesharesshortstockstermstradingversusweekwhatwhichwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Analyst Moves: SBUX, NDSN
Daily Dividend Report: KFT, MRK, C, WRB, DCI
Analyst Moves: SBUX, NDSN
Weekly Market Wrap: May 11, 2012
Week Ahead Market Report: May 14, 2012
Weekly Market Wrap: May 18, 2012
